Xencor, Inc. (XNCR) Q1 2023 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good afternoon, and thank you for standing by. Welcome to Zencore's first quarter 2023 conference. All participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. Please be advised that this call is going to be recorded at the company's request. Now, I would like to turn the call over to your speaker today, Charles Lillies from the Head of Corporate Communications and Investor Relations. Go ahead, Charles. Thank you, and good afternoon. Earlier today, we issued a press release with outlines of the topics we plan to discuss today. It's available at www.cencor.com. Providing abbreviated comments on the call is Basil Dekiat, President and Chief Executive Officer. Afterward, we will open up the call for your questions, and we will be joined by Alan Yang, Chief Medical Officer, John Desjarlais, Chief Scientific Officer, John Cush, Chief Financial Officer, as well as Nancy Valenti, Chief Development Officer. Before we begin, I would like to remind you that during the course of this conference call, Zencore Management may make forward-looking statements, including statements regarding the company's future financial and operating results, future market conditions, plans and objectives of management, future operations, the company's partnering efforts, capital requirements, future product offerings, and research and development programs. These forward-looking statements are not historical facts, but rather are based on our current expectations and beliefs and are based on information currently available to us. The outcome of the events described in these forward-looking statements are subject to known and unknown risks, uncertainties, and other factors that could cause actual results to differ materially from the resu...